| Robert Q Scacheri, MD | |
|
200 Banning St, Suite 320, Dover, DE 19904-3485 | |
| (302) 674-0223 | |
| (302) 674-0109 |
| Full Name | Robert Q Scacheri |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 200 Banning St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487638136 | NPI | - | NPPES |
| 000806401 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | C10005025 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dedicated To Women Ob-gyn, P.a. | 0446290456 | 21 |
News Archive
The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.
Inpatient hospital treatment accounts for the largest proportion of health care spending in the U.S., with the use of diagnostic imaging services such as MRIs, frequently implicated as the probable cause. A new analysis finds that the biggest expense may not be imaging technology but from supplies including medical devices, such as stents and artificial joints.
QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.
Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.
A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.
› Verified 5 days ago
| Entity Name | Dedicated To Women Ob-gyn, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548291891 PECOS PAC ID: 0446290456 Enrollment ID: O20050510000321 |
News Archive
The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.
Inpatient hospital treatment accounts for the largest proportion of health care spending in the U.S., with the use of diagnostic imaging services such as MRIs, frequently implicated as the probable cause. A new analysis finds that the biggest expense may not be imaging technology but from supplies including medical devices, such as stents and artificial joints.
QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.
Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.
A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.
› Verified 5 days ago
| Entity Name | Ob Hospitalist Services Delaware Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619304300 PECOS PAC ID: 4880813385 Enrollment ID: O20140916000857 |
News Archive
The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.
Inpatient hospital treatment accounts for the largest proportion of health care spending in the U.S., with the use of diagnostic imaging services such as MRIs, frequently implicated as the probable cause. A new analysis finds that the biggest expense may not be imaging technology but from supplies including medical devices, such as stents and artificial joints.
QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.
Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.
A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Q Scacheri, MD 200 Banning Street, Suite 320, Dover, DE 19904-3530 Ph: (302) 674-0223 | Robert Q Scacheri, MD 200 Banning St, Suite 320, Dover, DE 19904-3485 Ph: (302) 674-0223 |
News Archive
The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.
Inpatient hospital treatment accounts for the largest proportion of health care spending in the U.S., with the use of diagnostic imaging services such as MRIs, frequently implicated as the probable cause. A new analysis finds that the biggest expense may not be imaging technology but from supplies including medical devices, such as stents and artificial joints.
QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the launch of its ICD-10 Countdown Program. This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10 educational tools and services to guide healthcare providers through the ICD-10 conversion.
Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.
A team of University of Alberta researchers has discovered a way to use 3-D bioprinting technology to create custom-shaped cartilage for use in surgical procedures. The work aims to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.
› Verified 5 days ago
Robert J Scacheri, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 540 S Governors Ave, Ste 201 Ob Gyn Associates Of Dover Pa, Dover, DE 19904 Phone: 302-674-0223 Fax: 302-674-0109 | |
Laura B Moylan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-674-4700 | |
Garrett Hc Colmorgen, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 640 S State St Fl 6, Dover, DE 19901 Phone: 302-744-6220 Fax: 302-734-8454 | |
Dr. Andrew Robert Ward, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 320, Dover, DE 19904 Phone: 302-674-0223 | |
Dr. Nasreen Khan, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1113 S State St, Dover, DE 19901 Phone: 302-735-8720 Fax: 302-735-8724 | |
Robert B Hartmann, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning Street, Suite 320, Dover, DE 19904 Phone: 302-674-0223 Fax: 302-674-0109 | |
Michelle H Cooper, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning Street, Suite 320, Dover, DE 19904 Phone: 302-674-0223 Fax: 302-674-0109 |